2009 - 2011 Biomechanical analysis of the protective function for the articular cartilage caused by the capsule and labrum of the hip join
2000 - 2001 日本人の骨格形態に適した人工関節の研究開発
1999 - 2001 凹凸パターンを付加する人工関節摺動面の表面改質
2000 - 2001 MECHANISM OF REMODELING PHENOMENON INDUCED BY FUNCTIONAL ADAPTATION OF THE IN-SITU FROZEN-THAWED PATELLAR TENDON
1999 - 2000 日本人の骨格形態に適した人工関節の研究開発
1992 - 新しい人工股関節の研究開発
1992 - research and development of new artificial joint
低摩耗人工股関節の研究開発
research and development of new low frictional artificial joint
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金伊藤 浩151
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
寄附金人工関節講座353
人工関節の医師主導治験地域ネットワークモデルの構築
ゆるむ事のない人工関節開発へのブルークスルー
ゆるむ事のない人工関節開発へのブルークスルー
Show all
Papers (243):
Tanino H., Mitsutake R., Takagi K., Ito H. Does a Commercially Available Augmented Reality-based Portable Hip Navigation System Improve Cup Positioning During THA Compared With the Conventional Technique? A Randomized Controlled Study. Clin Orthop Relat Res. 2024. 482. 3. 458-467
Tanino H., Mitsutake R., Ito H. Measurement accuracy of the acetabular cup position using an inertial portable hip navigation system with patients in the lateral decubitus position. Sci. Rep. 2024. 14. 1. 1158
Higa M., Tanino H., Ito H., Banks SA. Correction: Soft-tissue tension during total hip arthroplasty measured in four patients and predicted using a musculoskeletal model. J Exp Orthop. 2023. 10. 1. 148
Higa M., Tanino H., Ito H., Banks SA. Soft-tissue tension during total hip arthroplasty measured in four patients and predicted using a musculoskeletal model. J Exp Orthop. 2023. 10. 1. 130
AGENT FOR PREVENTING ONSET OF IDIOPATHIC OSTEONECROSIS OF FEMORAL HEAD AND/OR SUPRE (AGENT FOR PREVENTING ONSET OF IDIOPATHIC OSTEONECROSIS OF FEMORAL HEAD AND/OR SUPRESSING PROGRESS OF SAME)